We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Events

27 Jan 2025 - 30 Jan 2025
15 Feb 2025 - 17 Feb 2025

First of Its Kind Multi-Stage Drug-Coated Balloon Technology to Help Fight GI Stenosis

By HospiMedica International staff writers
Posted on 09 Jun 2023
Print article
Image: ProTractX3 TTS DCB has been granted US FDA’s breakthrough device designation (Photo courtesy of GIE Medical)
Image: ProTractX3 TTS DCB has been granted US FDA’s breakthrough device designation (Photo courtesy of GIE Medical)

For decades, the approach to treating gastrointestinal (GI) strictures has remained largely unchanged. Now, an innovative technology offers a potential breakthrough in treating individuals with challenging GI strictures, leading to simpler, more cost-effective, and less invasive patient care.

GIE Medical (Brooklyn Park, MN, USA) has developed ProTractX3 TTS DCB for the dilation of recurring benign esophageal strictures in adult patients. These strictures, linked to the narrowing of the esophagus, cause obstructive symptoms in such patients. The ProTractX3 3-Stage TTS DCB is a balloon coated with the chemotherapeutic agent paclitaxel. This drug-coated balloon (DCB), deployable through the scope, presents a novel solution for GI stricture treatment, potentially ensuring long-term sustained patency and reducing the need for multiple treatments.

In December 2022, GIE Medical initiated two extensive, multicenter randomized controlled clinical trials in the United States. These trials are designed to examine the performance of the company's pioneering multi-stage DCB technology, ProTractX3 TTS DCB. The FDA Center for Devices and Radiological Health (CDRH) has awarded GIE Medical the Breakthrough Device Designation to speed up the development of its ProTractX3 TTS DCB. This designation is granted as the device shows significant potential to offer a more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions compared to the existing standard of care.

"We are honored to have our drug-coated balloon catheters selected for the FDA's Breakthrough Device Program for esophageal strictures. This may provide U.S. patients faster access to our novel DCB technology, with the potential to provide safer and more effective treatment," said Lixiao Wang, chairman and CEO of GIE Medical. "This designation will give U.S. gastrointestinal physicians exciting new tools to fight GI stenosis."

Related Links:
GIE Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Mattress Replacement System
Carilex DualPlus
New
Standing Sling
Sara Flex

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.